Items where Subject is "Australian and New Zealand Standard Research Classification > MEDICAL AND HEALTH SCIENCES (110000) > ONCOLOGY AND CARCINOGENESIS (111200) > Molecular Targets (111207)"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Authors/Creators | Item Type
Jump to: B | C | D | E | F | H | J | K | L | M | P | R | S | T | V | W | Y
Number of items at this level: 42.

B

Byron, Sara A., Gartside, Michael, Powell, Matthew A., Wellens, Candice L., Gao, Feng, Mutch, David G., et al. (2012) FGFR2 point mutations in 466 Endometrioid Endometrial Tumors : relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and Clinicopathological features. PLoS ONE, 7(2), e30801-e30801.
Number of full-text downloads 86
Number of citations in Scopus 62
Number of citations in Web of Science® 52

Byron, Sara A., Loch, David, & Pollock, Pamela M. (2012) Fibroblast growth factor receptor inhibition synergizes with paclitaxel and doxorubicin in endometrial cancer cells. International Journal of Gynecological Cancer, 22(9), pp. 1517-1526.
Number of full-text downloads 89
Number of citations in Scopus 8
Number of citations in Web of Science® 5

Byron, Sara A., Loch, David C. , Wellens, Candice L., Wortmann, Andreas, Wu, Jiayi, Wang, John, et al. (2012) Sensitivity to the MEK inhibitor E6201 in melanoma cells is associated with mutant BRAF and wildtype PTEN status. BMC Molecular Cancer, 11(75).
Number of full-text downloads 435
Number of citations in Scopus 17
Number of citations in Web of Science® 14

C

Chopin, L. K., Seim, I., Walpole, C. M., & Herington, A. C. (2012) The Ghrelin axis : does it have an appetite for cancer progression? Endocrine Reviews, 33(6), pp. 849-891.
Number of citations in Scopus 31
Number of citations in Web of Science® 28

D

Dong, Ying, Batra, Jyotsna, Anand, Kamal, Bapat, Sharmila, & Clements, Judith A. (2014) Transforming the future of treatment for ovarian cancer. Clinical & Experimental Pharmacology, 4(3), p. 1000157.
Number of full-text downloads 95

Dutton-Regester, Ken & Hayward, Nicholas K. (2012) Whole genome and exome sequencing of melanoma. Advances in Pharmacology, 65, pp. 399-435.
Number of citations in Scopus 10
Number of citations in Web of Science® 5

Dutton-Regester, Ken, Irwin, Darryl, Hunt, Priscilla, Aoude, Lauren G., Tembe, Varsha, Pupo, Gulietta M., et al. (2012) A high-throughput panel for identifying clinically relevant mutation profiles in melanoma. Molecular Cancer Therapeutics, 11(4), pp. 888-897.
Number of citations in Scopus 30
Number of citations in Web of Science® 28

E

Eggink, Florine A., Van Gool, Inge C., Leary, Alexandra, Pollock, Pamela M., Crosbie, Emma J., Mileshkin, Linda, et al. (2017) Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition. OncoImmunology, 6(2), Article number-e1264565.

F

Fuchs, Adrian V., Tse, Brian W.C., Pearce, Amanda K., Yeh, Mei-Chun, Fletcher, Nicholas L., Huang, Steve S., et al. (2015) Evaluation of polymeric nanomedicines targeted to PSMA: Effect of ligand on targeting efficiency. Biomacromolecules, 16(10), pp. 3235-3247.
Number of citations in Scopus 6
Number of citations in Web of Science® 8

H

Hao, J, Chen, H, Madigan, M C, Cozzi, P J, Beretov, J, Xiao, W, et al. (2010) Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression. British Journal of Cancer, 103(7), pp. 1008-1018.
Number of full-text downloads 9
Number of citations in Scopus 59
Number of citations in Web of Science® 55

Herington, A.C., Mertens-Walker, I., Lisle, J.E., Maharaj, M., & Stephenson, S.-A. (2014) Inhibiting Eph kinase activity may not be “Eph”ective for cancer treatment. Growth Factors, 32(6), pp. 207-213.
Number of citations in Scopus 1
Number of citations in Web of Science® 1

J

Jeske, Yvette W., Ali, Shamshad, Byron, Sara A., Gao, Feng, Mannel, Robert S., Ghebre, Rahel G., et al. (2017) FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic Oncology. (In Press)

Jingjing, You, Cozzi, Paul, Fitzgerald , Anna, Walsh, Bradley, Russell, Pamela J., Willcox, Mark, et al. (2012) Prostate cancer biomarkers and the emerging proteomic techniques used in biomarker research. In Watanabe, Hiroto S. (Ed.) Horizons in Cancer Research : Volume 47. Nova Science Publishers Inc, New York, pp. 1-36.

K

Karlsson, Thomas, Krakstad, Camilla, Tangan, Ingvild Løberg, Hoivik, Erling A., Pollock, Pamela M., Salvesen, Helga B., et al. (2017) Endometrial cancer cells exhibit high expression of p110β and its selective inhibition induces variable responses on PI3K signaling, cell survival and proliferation. Oncotarget, 8(3), pp. 3881-3894.
Number of full-text downloads 3

Krauthammer, Michael, Kong, Yong, Ha, Byung Hak, Evans, Perry, Bacchiocchi, Antonella, McCusker, James P, et al. (2012) Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nature Genetics, 44(9), pp. 1006-1014.
Number of citations in Scopus 420
Number of citations in Web of Science® 382

L

Levrier, Claire, Sadowski, Martin C., Rockstroh, Anja, Gabrielli, Brian, Kavallaris, Maria, Lehman, Melanie, et al. (2017) 6α-acetoxyanopterine: A novel structure class of mitotic inhibitor disrupting microtubule dynamics in prostate cancer cells. Molecular Cancer Therapeutics, 16(1), pp. 3-15.

Libério, Michelle S., Sadowski, Martin, Nelson, Colleen C., & Davis, Rohan A. (2014) Identification of eusynstyelamide B as a potent cell cycle inhibitor following the generation and screening of an ascidian-derived extract library using a real time cell analyzer. Marine Drugs, 12(10), pp. 5222-5239.
Number of full-text downloads 33
Number of citations in Scopus 6
Number of citations in Web of Science® 7

Lim, Yenkai, Sun, Charles Xiaohang, Tran, Peter, & Punyadeera, Chamindie (2016) Salivary epigenetic biomarkers in head and neck squamous cell carcinomas. Biomarkers in Medicine, 10(3), pp. 301-313.
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Lisle, J.E., Mertens-Walker, I., Stephens, C.R., Stansfield, S.H., Clements, J.A., Herington, A.C., et al. (2015) Murine, but not human, ephrin-B2 can be efficiently cleaved by the serine protease kallikrein-4: Implications for xenograft models of human prostate cancer. Experimental Cell Research, 333(1), pp. 136-146.
Number of citations in Scopus 2
Number of citations in Web of Science® 1

Lisle, Jessica E., Mertens-Walker, Inga, Rutkowski, Raphael, Herington, Adrian C., & Stephenson, Sally-Anne (2013) Eph receptors and their ligands : promising molecular biomarkers and therapeutic targets in prostate cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1835(2), pp. 243-257.
Number of citations in Scopus 14
Number of citations in Web of Science® 14

Loch, David & Pollock, Pamela M. (2012) Lineage-specific biomarkers predict response to FGFR inhibition. Cancer Discovery, 2, pp. 1081-1083.
Number of full-text downloads 45

M

Maddaluno, Luigi, Verbrugge, Sue Ellen, Martinoli, Chiara, Matteoli, Gianluca, Chiavelli, Andrea, Zeng, Yiping, et al. (2009) The adhesion molecule L1 regulates transendothelial migration and trafficking of dendritic cells. Journal of Experimental Medicine, 206(3), pp. 623-635.
Number of full-text downloads 40
Number of citations in Scopus 39
Number of citations in Web of Science® 37

Mertens-Walker, Inga, Fernandini, Bruno C., Maharaj, Mohanan S.N., Rockstroh, Anja, Nelson, Colleen C., Herington, Adrian C., et al. (2015) The tumour-promoting receptor tyrosine kinase, EphB4, regulates expression of Integrin-β8 in prostate cancer cells. BMC Cancer, 15(164).
Number of full-text downloads 21
Number of citations in Scopus 3
Number of citations in Web of Science® 3

Mertens-Walker, Inga, Lisle, Jessica E., Nyberg, William A., Stephens, Carson R., Burke, Leslie, Rutkowski, Raphael, et al. (2015) EphB4 localises to the nucleus of prostate cancer cells. Experimental Cell Research, 333(1), pp. 105-115.
Number of citations in Scopus 2
Number of citations in Web of Science® 2

Moore, Nicole L., Buchanan, Grant, Harris, Jonathan M., Selth, Luke A., Bianco-Miotto, Tina, Hanson, Adrienne R., et al. (2012) An androgen receptor mutation in the MDA-MB-453 cell line model of molecular apocrine breast cancer compromises receptor activity. Endocrine Related Cancer, 19(4), pp. 599-613.
Number of citations in Scopus 25
Number of citations in Web of Science® 19

P

Packer, Leisl M., Geng, Xinyan, Bonazzi, Vanessa F., Ju, Robert, Mahon, Clare, Cummings, Margaret, et al. (2017) PI3K inhibitors synergize with FGFR inhibitors to enhance antitumor responses in FGFR2-mutant endometrial cancers. Molecular Cancer Therapeutics. (In Press)

Paul, P.J., Raghu, D., Chan, A.-L., Gulati, T., Lambeth, L., Takano, E., et al. (2016) Restoration of tumor suppression in prostate cancer by targeting the E3 ligase E6AP. Oncogene, 35(48), pp. 6235-6245.

R

Rhee, H., Heathcote, P., Wood, S., Greenslade, S., Russell, P., Nelson, C., et al. (2015) Clinical application of biomarkers in prostate cancer in men with metabolic syndrome project: Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) in diagnosing localised prostate cancer. In 24th Malaysian Urological Conference (MUC 2015), 19 November 2015, Malaysia.

Rhee, Handoo, Vela, Ian, Gunter, Jennifer, Jovanovic, Lidija, Hollier, Brett, Williams, Elizabeth, et al. (2015) Clinical application of biomarkers in prostate cancer in men with metabolic syndrome project: Clinical evaluation of prognostic and metabolic benefits of Metformin in prostate cancer. In Urological Society of Australia and New Zealand 68th Annual Scientific Meeting, 11–14 April 2015, Adelaide, Australia.

Rutowski, Raphael, Mertens-Walker, Inga, Lisle, Jessica E, Herington, Adrian C., & Stephenson, Sally-Anne (2012) Evidence for a dual function of EphB4 as tumor promoter and suppressor regulated by the absence or presence of the ephrin-B2 ligand. International Journal of Cancer, 131(5), E614-E624.
Number of citations in Scopus 21
Number of citations in Web of Science® 15

S

Seim, Inge, Jeffery, Penny L., Herington, Adrian C., & Chopin, Lisa K. (2015) Comparative analysis reveals loss of the appetite-regulating peptide hormone ghrelin in falcons. General and Comparative Endocrinology, 216, pp. 98-102.
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Soekmadji, Carolina, Riches, James D., Russell, Pamela J., Ruelcke, Jayde E., McPherson, Stephen, Wang, Chenwei, et al. (2016) Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer. Oncotarget. (In Press)
Number of full-text downloads 14

Soekmadji, Carolina, Ruelcke, Jayde E., Wang, Chenwei, Riches, James D., McPherson, Stephen, Russell, Pamela, et al. (2015) Extracellular vesicles mediate paracrine signalling in androgen deprived prostate cancer. In 2nd Prostate Cancer World Congress, 17-21 August 2015, Cairns Convention Centre, Cairns, Qld.
Number of full-text downloads 6

Stephenson, Sally-Anne, Douglas, Evelyn L., Mertens-Walker, Inga, Lisle, Jessica E., Maharaj, Mohanan S.N., & Herington, Adrian C. (2015) Anti-tumour effects of antibodies targeting the extracellular cysteine-rich region of the receptor tyrosine kinase EphB4. Oncotarget, 6(10), pp. 7554-7569.
Number of full-text downloads 36
Number of citations in Scopus 1
Number of citations in Web of Science® 1

T

Tevz, Gregor, Hossain, Akther, Bock, Nathalie, Jeet, Varinder, Bathgate, Ross A., Williams, Elizabeth D., et al. (2015) Impeding the adaptive response of prostate cancer to androgen targeted therapies with relaxin receptor antagonist. In 2nd Prostate Cancer World Congress, 17-21 August 2015, Cairns Convention Centre, Cairns, Qld.
Number of full-text downloads 10

Tse, B.W.C., Cowin, G.J., Soekmadji, C., Jovanovic, L., Vasireddy, R., Ling, M.T., et al. (2014) Enhancing MRI of prostate cancer using PSMA-targeting iron oxide magnetic nanoparticles. In 67th Annual Scientific Meeting of the Urological Society of Australia and New Zealand (USANZ 2014), 16–19 March 2014, Brisbane, Qld.

Tse, Brian W-C, Fuchs, Adrian V., Huang, Steve S., Heston, Warren DW, Yeh, Mei-Chun, Whittaker, Andrew K., et al. (2015) Multimodal hyperbranched polymers targeting prostate specific membrane antigen (PSMA) for imaging of prostate cancer. In 2nd Prostate Cancer World Congress, 17-21 August 2015, Cairns Convention Centre, Cairns, Qld.

V

Vasireddy, Raja S. & Nelson, Colleen (2014) Current trends in prostate cancer treatment and drug resistance. In Morais, Christudas (Ed.) Advances in Drug Resistance Research. Nova Science Publishers, New York, pp. 155-176.

Vela, Ian & Chen, Yu (2015) Prostate cancer organoids: A potential new tool for testing drug sensitivity. Expert Review of Anticancer Therapy, 15(3), pp. 261-263.
Number of citations in Scopus 4
Number of citations in Web of Science® 5

Volpert, Marianna, Tse, Brian W.C., Stylianou, Nataly, Ratther, Ellca, McPherson, Stephen, Costa, Taylor, et al. (2015) Targeting neuropilin-1 to inhibit prostate cancer invasion and metastasis. In 2nd Prostate Cancer World Congress, 17-21 August 2015, Cairns Convention Centre, Cairns, Qld.
Number of full-text downloads 16

W

Williams, Elizabeth D. & Thompson, Erik W. (2015) How cancer doctors use personalized medicine to target variations unique to each tumour. Conversation.
Number of full-text downloads 23

Y

You, Jingjing, Willcox, Mark, Fitzgerald, Anna, Schiller, Belinda, Cozzi, Paul J., Russell, Pamela J., et al. (2015) Absolute quantification of human tear lactoferrin using multiple reaction monitoring technique with stable-isotopic labeling. Analytical Biochemistry, 496, pp. 30-34.

This list was generated on Sun Apr 16 10:12:57 2017 AEST.